[go: up one dir, main page]

DK2427449T3 - Vinylindazolylforbindelser - Google Patents

Vinylindazolylforbindelser

Info

Publication number
DK2427449T3
DK2427449T3 DK10717402.1T DK10717402T DK2427449T3 DK 2427449 T3 DK2427449 T3 DK 2427449T3 DK 10717402 T DK10717402 T DK 10717402T DK 2427449 T3 DK2427449 T3 DK 2427449T3
Authority
DK
Denmark
Prior art keywords
vinylindazolyl
compounds
vinylindazolyl compounds
Prior art date
Application number
DK10717402.1T
Other languages
English (en)
Inventor
Daohong Chen
Hong-Yu Li
Genshi Zhao
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK2427449T3 publication Critical patent/DK2427449T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK10717402.1T 2009-05-07 2010-05-04 Vinylindazolylforbindelser DK2427449T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17629009P 2009-05-07 2009-05-07
US30141610P 2010-02-04 2010-02-04
PCT/US2010/033487 WO2010129509A1 (en) 2009-05-07 2010-05-04 Vinyl indazolyl compounds

Publications (1)

Publication Number Publication Date
DK2427449T3 true DK2427449T3 (da) 2013-04-22

Family

ID=42238704

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10717402.1T DK2427449T3 (da) 2009-05-07 2010-05-04 Vinylindazolylforbindelser

Country Status (35)

Country Link
US (1) US8268869B2 (da)
EP (1) EP2427449B1 (da)
JP (1) JP5555314B2 (da)
KR (1) KR101373910B1 (da)
CN (1) CN102421769B (da)
AR (1) AR078411A1 (da)
AU (1) AU2010246114B2 (da)
BR (1) BRPI1013748A2 (da)
CA (1) CA2760535C (da)
CL (1) CL2011002781A1 (da)
CO (1) CO6450624A2 (da)
CR (1) CR20110580A (da)
DK (1) DK2427449T3 (da)
EA (1) EA018149B1 (da)
EC (1) ECSP11011441A (da)
ES (1) ES2408117T3 (da)
HK (1) HK1163665A1 (da)
HN (1) HN2011002809A (da)
HR (1) HRP20130323T1 (da)
IL (1) IL216004A (da)
JO (1) JO2860B1 (da)
MA (1) MA33244B1 (da)
ME (1) ME01462B (da)
MX (1) MX2011011342A (da)
MY (1) MY160390A (da)
NZ (1) NZ595553A (da)
PE (2) PE20160124A1 (da)
PL (1) PL2427449T3 (da)
PT (1) PT2427449E (da)
RS (1) RS52795B (da)
SG (1) SG175909A1 (da)
SI (1) SI2427449T1 (da)
TW (1) TWI382982B (da)
UA (1) UA104756C2 (da)
WO (1) WO2010129509A1 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3062B1 (ar) * 2010-10-05 2017-03-15 Lilly Co Eli R)-(e)-2-(4-(2-(5-(1-(3، 5-داي كلورو بيريدين-4-يل)إيثوكسي)-1h-إندازول-3-يل)?ينيل)-1h-بيرازول-1-يل)إيثانول بلوري
WO2012088266A2 (en) 2010-12-22 2012-06-28 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
AU2013228389A1 (en) 2012-03-08 2014-09-25 Astellas Pharma Inc. Novel FGFR3 fusion product
SMT202000673T1 (it) 2012-06-13 2021-01-05 Incyte Holdings Corp Composti triciclici sostituiti come inibitori di fgfr
US20150203589A1 (en) 2012-07-24 2015-07-23 The Trustees Of Columbia University In The City Of New York Fusion proteins and methods thereof
WO2014026125A1 (en) 2012-08-10 2014-02-13 Incyte Corporation Pyrazine derivatives as fgfr inhibitors
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
AU2014236947A1 (en) 2013-03-15 2015-09-03 The Trustees Of Columbia University In The City Of New York Fusion proteins and methods thereof
SG11201508328PA (en) 2013-04-19 2015-11-27 Incyte Corp Bicyclic heterocycles as fgfr inhibitors
CN103819396B (zh) * 2014-02-26 2016-06-15 四川大学 一种手性的1-(3,5-二氯吡啶-4-基)-乙醇的合成方法
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
EP3925979A3 (en) 2014-12-23 2022-03-23 The Trustees of Columbia University in the City of New York Fgfr-tacc fusion proteins and methods thereof
UA121669C2 (uk) 2015-02-20 2020-07-10 Інсайт Корпорейшн Біциклічні гетероцикли як інгібітори fgfr
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
WO2016134294A1 (en) 2015-02-20 2016-08-25 Incyte Corporation Bicyclic heterocycles as fgfr4 inhibitors
CN105906621A (zh) * 2015-04-06 2016-08-31 四川百利药业有限责任公司 用作fgfr抑制剂的乙醇类化合物
WO2016187767A1 (en) * 2015-05-25 2016-12-01 Hutchison Medipharma Limited Pharmaceutical compositions and use thereof
CN107922349B (zh) * 2015-08-07 2021-05-07 哈尔滨珍宝制药有限公司 作为fgfr和vegfr抑制剂的乙烯基化合物
EP3339305B1 (en) 2015-08-20 2022-05-04 Zhejiang Hisun Pharmaceutical Co., Ltd Indole derivative, preparation method thereof, and use thereof in pharmaceutical drug
CN107459519A (zh) 2016-06-06 2017-12-12 上海艾力斯医药科技有限公司 稠合嘧啶哌啶环衍生物及其制备方法和应用
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
FI3788047T3 (fi) 2018-05-04 2024-11-02 Incyte Corp Fgft-estäjän kiinteitä muotoja ja menetelmiä niiden valmistamiseksi
MX2020011639A (es) 2018-05-04 2021-02-15 Incyte Corp Sales de un inhibidor de receptores de factor de crecimiento de fibroblastos (fgfr).
WO2020185532A1 (en) 2019-03-08 2020-09-17 Incyte Corporation Methods of treating cancer with an fgfr inhibitor
WO2021007269A1 (en) 2019-07-09 2021-01-14 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
WO2021067374A1 (en) 2019-10-01 2021-04-08 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
JOP20220083A1 (ar) 2019-10-14 2023-01-30 Incyte Corp حلقات غير متجانسة ثنائية الحلقة كمثبطات لـ fgfr
US11566028B2 (en) 2019-10-16 2023-01-31 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
CN114072387B (zh) * 2019-11-06 2024-03-08 暨南大学 吲唑类化合物及其药用组合物和应用
EP4069696A1 (en) 2019-12-04 2022-10-12 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
PE20221504A1 (es) 2019-12-04 2022-09-30 Incyte Corp Derivados de un inhibidor de fgfr
US20230115528A1 (en) * 2019-12-30 2023-04-13 Tyra Biosciences, Inc. Indazole compounds
WO2021146424A1 (en) 2020-01-15 2021-07-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
EP4186894B1 (en) * 2020-08-11 2024-12-04 Henan Medinno Pharmaceutical Technology Co., Ltd. Fgfr inhibitor compound and use thereof
EP4323405A1 (en) 2021-04-12 2024-02-21 Incyte Corporation Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
JP2024522189A (ja) 2021-06-09 2024-06-11 インサイト・コーポレイション Fgfr阻害剤としての三環式ヘテロ環
CN116554148B (zh) * 2022-12-13 2025-01-28 药康众拓(北京)医药科技有限公司 一种乙烯基吲唑类氘代fgfr抑制剂药物及用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6897231B2 (en) * 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto
EA006711B1 (ru) 2000-09-11 2006-02-24 Чирон Корпорейшн Хинолиноновые производные в качестве ингибиторов тирозинкиназы
US7495104B2 (en) * 2001-10-17 2009-02-24 Kirin Beer Kabushiki Kaisha Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors
EP1510516A4 (en) * 2002-05-31 2005-11-02 Eisai Co Ltd PYRAZOL COMPOUND AND MEDICAL COMPOSITION CONTAINING THEM
DE10342503A1 (de) * 2003-09-12 2005-04-14 Merck Patent Gmbh Benzyl-Benzimidazolylderivate
ES2308492T3 (es) 2004-05-26 2008-12-01 Pfizer, Inc. Derivados de indazol e indolona y su uso como productos farmaceuticos.
WO2007058626A1 (en) 2005-11-16 2007-05-24 S*Bio Pte Ltd Indazole compounds
US20070129364A1 (en) * 2005-12-07 2007-06-07 Han-Qing Dong Pyrrolopyridine kinase inhibiting compounds
CA2673095C (en) 2006-12-20 2016-03-15 Nerviano Medical Sciences S.R.L. Indazole derivatives as kinase inhibitors for the treatment of cancer
US7737149B2 (en) * 2006-12-21 2010-06-15 Astrazeneca Ab N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof
KR20100025553A (ko) 2007-06-05 2010-03-09 쉐링 코포레이션 암 치료용 erk 억제제로서의 폴리사이클릭 인다졸 유도체 및 이의 용도
DE102007028521A1 (de) 2007-06-21 2008-12-24 Merck Patent Gmbh Indazolamidderivate
EP2265270A1 (en) * 2008-02-04 2010-12-29 OSI Pharmaceuticals, Inc. 2-aminopyridine kinase inhibitors

Also Published As

Publication number Publication date
US20100286209A1 (en) 2010-11-11
PL2427449T3 (pl) 2013-08-30
KR20120004511A (ko) 2012-01-12
RS52795B (en) 2013-10-31
EA018149B1 (ru) 2013-05-30
PE20120812A1 (es) 2012-07-08
JP2012526126A (ja) 2012-10-25
IL216004A (en) 2014-01-30
EP2427449B1 (en) 2013-04-03
CN102421769A (zh) 2012-04-18
MA33244B1 (fr) 2012-05-02
AR078411A1 (es) 2011-11-09
AU2010246114B2 (en) 2012-12-06
MX2011011342A (es) 2011-11-18
JO2860B1 (en) 2015-03-15
HN2011002809A (es) 2013-07-22
PT2427449E (pt) 2013-05-06
EA201171367A1 (ru) 2012-04-30
CL2011002781A1 (es) 2012-05-25
ME01462B (me) 2014-04-20
HK1163665A1 (en) 2012-09-14
WO2010129509A1 (en) 2010-11-11
BRPI1013748A2 (pt) 2016-04-05
MY160390A (en) 2017-03-15
UA104756C2 (uk) 2014-03-11
HRP20130323T1 (en) 2013-05-31
CR20110580A (es) 2012-01-06
ECSP11011441A (es) 2011-12-30
NZ595553A (en) 2013-05-31
TWI382982B (zh) 2013-01-21
US8268869B2 (en) 2012-09-18
PE20160124A1 (es) 2016-02-24
ES2408117T3 (es) 2013-06-18
EP2427449A1 (en) 2012-03-14
CN102421769B (zh) 2014-04-02
CA2760535C (en) 2014-01-14
SG175909A1 (en) 2011-12-29
KR101373910B1 (ko) 2014-03-12
CA2760535A1 (en) 2010-11-11
CO6450624A2 (es) 2012-05-31
SI2427449T1 (sl) 2013-05-31
AU2010246114A1 (en) 2011-11-03
TW201105652A (en) 2011-02-16
IL216004A0 (en) 2012-01-31
JP5555314B2 (ja) 2014-07-23

Similar Documents

Publication Publication Date Title
CY2017026I1 (el) Τετρακυκλικη ενωση
SMT201600008B (it) Composti di piridazinone
DK2427449T3 (da) Vinylindazolylforbindelser
BR112012006859A2 (pt) compostos
BRPI1008774A2 (pt) espiroamida substituída
BRPI1013614A2 (pt) compostos substituídos de espiro-amida
DK2414015T3 (da) Laryngoskopsystem
DK2411442T4 (da) Umættet polyesterresin
DE112010004215A5 (de) Hydrostataktor
DE112010002949A5 (de) Kupplungstastpunkte
EP2397521A4 (en) BENZOXAZINE RESIN COMPOSITION
BRPI1005525A2 (pt) compostos de azaazuleno
EP2401340A4 (en) POLYMER MODIFIER AGENTS
BRPI1013868A2 (pt) composto diaciletilenodiamina
DK2430035T3 (da) Uracylspipooxetannukleosider
BRPI1008827A2 (pt) deisobutenizador
BRPI1014968A2 (pt) subalargador
DE112010002728A5 (de) Turboinhalator
UY33156A (es) Nuevos compuestos tienopirrol
HK1176606A1 (zh) -吡啶酮化合物
DE112010004249A5 (de) Spindelaktor
DE112009005323A5 (de) Hebelarmprüfmaschine
DE112009005462T8 (de) Lenkungsssteuervorrichtung
BRPI1008070A2 (pt) tricianoboratos
BR112012004964A2 (pt) girocóptero